BamSEC and AlphaSense Join Forces
Learn More

Theriva Biologics, Inc.

NYSE American: TOVX    
Share price (12/20/24): $1.14    
Market cap (12/20/24): $3.172 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 1 page Filed in the Office of Secretary of State State of Nevada Business Number E0776232008-6 Filing Number 20244272749 Filed on 8/22/2024 11:28:00 Am Number of Pages 1
12/34/56
EX-3.1
from 8-K 8 pages Second Amended and Restated By-Laws of Theriva Biologics, Inc. (A Nevada Corporation) Adopted: August 9, 2023 Effective: October 3, 2023 Article 1 Stockholders
12/34/56
EX-3.3
from 8-K 7 pages Amended and Restated By-Laws of Theriva Biologics, Inc. (A Nevada Corporation) Adopted and Effective: October 12, 2022 Article 1 Stockholders
12/34/56
EX-3.2
from 8-K 1 page Filed in the Office of Secretary of State State of Nevada Business Number E0776232008-6 Filing Number 20222683054 Filed on 10/11/2022 11:43:00 Am Number of Pages 1
12/34/56
EX-3.1
from 8-K 2 pages Filed in the Office of Secretary of State State of Nevada Business Number E0776232008-6 Filing Number 20222683090 Filed on 10/11/2022 11:43:00 Am Number of Pages 2
12/34/56
EX-3.2
from DEFA14A 15 pages Synthetic Biologics, Inc. Certificate of Designation of Series D Convertible Preferred Stock Pursuant to Section 78.1955 of the Nevada Revised Statutes
12/34/56
EX-3.1
from DEFA14A 14 pages Synthetic Biologics, Inc. Certificate of Designation of Series C Convertible Preferred Stock Pursuant to Section 78.1955 of the Nevada Revised Statutes
12/34/56
EX-3.2
from 8-K 15 pages Synthetic Biologics, Inc. Certificate of Designation of Series D Convertible Preferred Stock Pursuant to Section 78.1955 of the Nevada Revised Statutes
12/34/56
EX-3.1
from 8-K 14 pages Synthetic Biologics, Inc. Certificate of Designation of Series C Convertible Preferred Stock Pursuant to Section 78.1955 of the Nevada Revised Statutes
12/34/56
EX-3.1
from 8-K 1 page Filed in the Office of Secretary of State State of Nevada Business Number E0776232008-6 Filing Number 20222494678 Filed on 7/21/2022 1:30:00 Am Number of Pages 1
12/34/56
EX-3.1
from 8-K 5 pages Amended and Restated By-Laws of Synthetic Biologics, Inc. (A Nevada Corporation) Adopted and Effective: July 11, 2022 Article 1 Stockholders
12/34/56
EX-3.1
from 8-K/A 2 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 1 page Certificate, Amendment or Withdrawal of Designation
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Amendment to Certificate of Designation for Nevada Profit Corporations
12/34/56
EX-3.1
from 8-K 17 pages Certificate of Designation for Nevada Profit Corporations
12/34/56
EX-3.10
from S-1/A 17 pages Synthetic Biologics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Nevada Revised Statutes 78.1955
12/34/56
EX-3.1
from 8-K ~1 page Certificate of Amendment to Articles of Incorporation for Nevada Profit Corporations
12/34/56
EX-3.1
from 8-K 1 page Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 13 pages Certificate of Designation of Series a Convertible Preferred Stock of Synthetic Biologics, Inc. Pursuant to Section 78.195 of the Nevada Revised Statute
12/34/56